PROactive study: (r)evolution in the therapy of diabetes?

被引：7

作者：

Ceriello, A ^{[1
]}

机构：

[1] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England

来源：

DIABETIC MEDICINE | 2005年 / 22卷 / 11期

关键词：

D O I：

10.1111/j.1464-5491.2005.01793.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1463 / 1464

页数：2

共 3 条

[1] The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance [J].

Da Ros, R ;

Assaloni, R ;

Ceriello, A .

DIABETIC MEDICINE, 2004, 21 (11) :1249-1252

[2] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[3]

Walter H, 2005, DRUGS, V65, P1, DOI 10.2165/00003495-200565010-00001

← 1 →